Dr. Alice Shaw videos

Here is an hour presentation from February 10, 2014 by Dr. Shaw through the IASLC.org web site. It is entitled “Management of Patients with ALK Positive NSCLC”. The target audience is oncologists. The WebEx webinar can be tricky to get to play (you need to download the WebEx reader). I could not get it to work on my iPad but was able to watch it on my laptop.

https://www.iaslc.org/webinars/2nd-webinar-iaslc-lung-cancer-grand-rounds-series-management-patients-alk-positive-nsclc

squanch wrote up a summary of about half of the video above. It is reply 5003238 from February 22, 2014, which is the sixth reply to the original question.

The summary can be found at http://www.inspire.com/groups/lung-cancer-survivors/discussion/did-anyone-hear-webinar-on-alk-on-feb-10/

Here is another short video from OncLive.com in which Dr. Shaw gives an update on LDK378 and Alectinib (CH542802 from Chugai/Roche)

http://m.youtube.com/watch?v=-Hd5SdclyaE

This entry was posted in alectinib - Alecensa from Chugai - Roche - GenenTech, ceritinib - Zykadia from Novartis, crizotinib - Xalkori from Pfizer, Experiences, Lung cancer, Potential Treatments, Regulatory applications & approvals, Research, Resistance to treatment, Side Effects. Bookmark the permalink.

Leave a Reply